Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Supportive Oncology|October 26, 2011
Animal models of mucositis: implications for therapyJoanne M Bowen, Rachel J Gibson, Dorothy M K Keefe
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 26, 2013
Predictors of acute adverse events from rapid rituximab infusionDora S P Lang, Dorothy M K Keefe, Tim Schultz, et al.
Clinical and Experimental Medicine|March 8, 2005
Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the ratR J Gibson, J M Bowen, A G Cummins, et al.
Current Drug Metabolism|January 20, 2009
Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of changeAndrea M Stringer, Rachel J Gibson, Joanne M Bowen, et al.
Oral Oncology|September 19, 2006
Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapyRichard M Logan, Rachel J Gibson, Stephen T Sonis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2006
Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damageJoanne M Bowen, Rachel J Gibson, Adrian G Cummins, et al.
International Journal of Radiation Oncology, Biology, Physics|August 16, 2005
Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changesAnn S J Yeoh, Joanne M Bowen, Rachel J Gibson, et al.
Oral Diseases|October 5, 2012
Matrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity?A R Al-Azri, R J Gibson, D M K Keefe, et al.
Chemotherapy|August 24, 2007
Establishment of a single-dose irinotecan model of gastrointestinal mucositisRachel J Gibson, Joanne M Bowen, Enrique Alvarez, et al.
Pageof 9